Peli BioThermal, the global name in temperature controlled packaging, announces the opening of a new network station and drop point in Incheon, South Korea—as the country eyes pharmaceutical development as a primary driver of economic growth. This network station is strategically located near the capital city of Seoul to enable the region to take advantage of the Crēdo on Demand rental option for temperature-controlled containers.
“South Korea is a significant player in the development of generic pharmaceuticals, and it’s already home to 40-plus multinational pharmaceutical companies,” said Dominic Hyde, Vice President of Crēdo on Demand at Peli BioThermal. “Having access to a high performance, flexible rental option for shipping temperature-sensitive pharmaceuticals can expand South Korea’s reach throughout Asia and beyond.”
GlobalData reports that South Korea’s pharmaceutical market is expected to climb to $23.3 billion by 2022. According to the Korean Ministry of Food and Drug Safety, pharmaceutical exports have experienced double digit annual growth in recent years — due to increasing shipments to Europe, Asia and North America.
The new drop point and network station joins more than 100 locations across the globe supporting Peli BioThermal’s Crēdo on Demand rental program. The Incheon location will service, refurbish, repair and condition Peli BioThermal’s reusable Crēdo Cargo and Crēdo Xtreme shipping containers.
Visit www.pelibiothermal.com to learn more about the wide range of Peli BioThermal products and offerings.
Peli BioThermal is a division of Peli Products, S.L.U., which is the European arm of Pelican Products, Inc., which is a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco.